Search / Trial NCT06227234

Evaluation of Foreign Body Airway Obstruction Interventions Through Simulation

Launched by UNIVERSITY OF CALGARY · Jan 17, 2024

Trial Information

Current as of October 04, 2024

Not yet recruiting

Keywords

Basic Life Support Foreign Body Airway Obstruction Abdominal Thrusts Layperson Airway Clearance Device Lifevac Dechoker

Description

Foreign body airway obstructions (FBAO, choking) result in significant mortality and morbidity globally . If left untreated, individuals suffering from airway obstructions will progress to unresponsiveness and die. For the first time in decades, a novel choking intervention is being promoted. Airway clearance devices (such as LifeVac© or Dechoker©) are non-powered suction-based devices being marketed by manufacturers as a safer, easier alternative to traditional choking interventions. However, a systematic review, conducted by Dunne et al, demonstrated insufficient evidence to recommend the...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Aged 18 years or older
  • * Able to communicate in English (to sign informed consent)
  • Exclusion Criteria:
  • - Physical disability limiting the performance/use of the interventions

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0